Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2005
11/09/2005EP1592665A2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/09/2005EP1592452A2 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology
11/09/2005EP1592450A2 Use of a volatile liquid at atmospheric pressure and ambient temperature for the production of pharmaceutical or biological compositions
11/09/2005EP1592431A1 Method of modulating il-6
11/09/2005EP1592420A1 Clindamycin phosphate foam
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1480983B1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
11/09/2005EP1480981B1 1-(alkyl), 1-(heteroaryl)alkyl and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1337220A4 Compositions having comfrey and methods for reducing retinoid-induced skin irritation
11/09/2005EP1328552A4 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof
11/09/2005EP1259514B9 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/09/2005EP1218376B1 Tyrosine kinase inhibitors
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1212421B1 Gas1 polypeptides
11/09/2005EP1204321B1 Super-active porcine growth hormone releasing hormone analog
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005EP1130964B1 Therapeutic anti-fungal nail preparation
11/09/2005EP1096918B1 Skin and tissue care and/or treatment agent
11/09/2005EP1087747B1 Foaming composition for hair care
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP0960192B1 Synthetic polynucleotides
11/09/2005EP0751992B1 Vascular endothelial growth factor 2
11/09/2005CN1694901A Kdr peptides and vaccines comprising the same
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/09/2005CN1226047C Pharmaceutical compositions
11/09/2005CN1226044C Oral liquid for relieving rheumatic pains and stopping itch, and its preparation method
11/09/2005CN1226043C Oral tablet for treating psoriasis and its preparation method
11/08/2005US6963012 2-amino-2-[4-(3-benzyloxyphenoxy)-2-chlorophenyl]propyl-1,3-propanediol for example; treating autoimmune diseases such as rheumatoid arthritis, transplant rejection, psoriasis, dermatitis
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962996 Inhibitors of p38
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962944 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
11/08/2005US6962941 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis
11/08/2005US6962940 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962925 useful for the treatment of the pathologies mediated by the enzyme or for agricultural uses as plant growth regulators or herbicides
11/08/2005US6962915 Antiinflammatory agents
11/08/2005US6962908 Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
11/08/2005US6962712 Cosmetic or dermatological composition comprising of a combination of an elastase inhibitor of the N-acylaminoamide family and at least one antifungal agent or at least one antibacterial agent
11/08/2005US6962697 Use of sphingomyelinase to increase the levels of skin and mucosal ceramides, and dermatological and cosmetic compositions suitable for topical application containing same
11/08/2005CA2382599C Flushable disposable polymeric products
11/08/2005CA2269501C Pellets having a core coated with an antifungal and a polymer
11/08/2005CA2256085C Association of procysteine with a polyol
11/08/2005CA2251690C New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/03/2005WO2005103046A1 Selenophen derivatives and the use of preventing and/or treating the diseases relating to protein aging thereof
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005102388A1 Novel blt2-mediated disease, and blt2 binding agent and compound
11/03/2005WO2005102321A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
11/03/2005WO2005102319A2 Use of melatonin in preventing postoperative complications
11/03/2005WO2005102250A1 Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound and a polymer containing said monomer compound and the use thereof
11/03/2005US20050245750 Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
11/03/2005US20050245736 Low molecular weight oversulfated polysaccharide
11/03/2005US20050245609 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
11/03/2005US20050245586 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12
11/03/2005US20050245575 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
11/03/2005US20050245567 Novel quinuclidine derivatives and their use
11/03/2005US20050245564 Methods and compositions related to IRM compounds and toll-like receptor pathways
11/03/2005US20050245562 1h-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases
11/03/2005US20050245552 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245538 Dipeptidyl peptidase inhibitor; antidiabetic agents; obesity; viricides; anticancer agents; oral diseases; autoimmune disease
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245514 Novel physiologically active substances
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050244915 Assays for modulators of asparaginyl hydroxylase
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005US20050244350 Composition including a pigment assembly comprising a mica core
11/03/2005DE102005010142A1 Composition for activating hair roots, especially to combat androgenetic alopecia, containing synergistic combination of caffeine and plant extract with phyto-estrogenic action
11/03/2005DE102004017996A1 Stable anionic liposome depot system for prolonged release of protein or peptide drugs, e.g. insulin, comprising phosphatidyl choline, cholesterol, anionic lipid(s) and cationic polymer
11/03/2005CA2564161A1 Melatonin and its use in preventing postoperative complications
11/03/2005CA2562417A1 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005CA2561393A1 Use of a sphingoid base associated with nicotinic acid or a nicotinic acid amide in the form of a depigmentation agent
11/02/2005EP1591446A1 Thienopyrimidine compounds and use thereof
11/02/2005EP1591444A1 CCR5 antagonists useful for treating aids
11/02/2005EP1591441A1 Carboxylic acid compounds
11/02/2005EP1591437A2 Interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
11/02/2005EP1591129A2 Use of neurotoxic component of botulinum toxin for treating pain associated with cervical dystonia or bepharospasm
11/02/2005EP1591128A1 Thymosin beta 4 promotes wound repair
11/02/2005EP1591125A1 Pharmaceutical composition comprising extracts of lichens and hypericum
11/02/2005EP1591118A1 Use of melatonin in preventing postoperative complications
11/02/2005EP1590701A2 Method and apparatus for correcting vision using an electro-active phoropter
11/02/2005EP1590324A1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb
11/02/2005EP1589987A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing
11/02/2005EP1589977A1 Topical ointment for vesicating chemical warfare agents
11/02/2005EP1589941A1 Composition for preventive treatment of cold sores
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1501833B1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
1 ... 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 ... 1065